Regulatory Status: CE-IVD, LDT
Quantitation of CMV from plasma, serum or CSF.
This is part of our Immunosuppresion test menu, as an aid in CMV diagnosis and management of transplant or immunocompromised patients who have been diagnosed with CMV infection. It can be used to determine if there is reactivation of latent disease in immunocompromised patients, and monitoring of treatment progress in CMV disease.
Plasma: 99 to 19,800,000 IU/mL
Serum: 119 to 19,800,000 IU/mL
CSF: 161 to 19,800,000 IU/mL